Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Bacillus Coagulans market will register a 8.1% CAGR in terms of revenue, the global market size will reach US$ 29 million by 2024, from US$ 18 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Bacillus Coagulans business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Bacillus Coagulans market by product type, application, key manufacturers and key regions and countries.
This study considers the Bacillus Coagulans value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Below 100 B
100-200 B
Above 200 B
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Drugs
Food
Beverage
Supplement Products
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ganeden
Sabinsa
Mitsubishi
Nebraska Cultures
Synbiotech
Syngen Biotech
Sanzyme
Microbax
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Bacillus Coagulans consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Bacillus Coagulans market by identifying its various subsegments.
Focuses on the key global Bacillus Coagulans manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Bacillus Coagulans with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Bacillus Coagulans submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Bacillus Coagulans . Industry analysis & Market Report on Bacillus Coagulans is a syndicated market report, published as Global Bacillus Coagulans Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Bacillus Coagulans market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.